{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:54:37Z","timestamp":1783036477808,"version":"3.54.6"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Patients with advanced cancer experience substantial symptom burden that impairs health-related quality of life (HRQOL) and contributes to emergency department (ED) visits and hospitalizations. Evidence for application (app)-facilitated palliative care interventions remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate whether an app-facilitated palliative care intervention integrating digital symptom monitoring with nurse-led clinical follow-up can improve outcomes among patients with advanced cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This multicenter randomized clinical trial was conducted at 6 palliative care clinics in Hong Kong from January 25, 2023, to February 5, 2025. Community-dwelling adults with advanced solid cancer who were no longer receiving systemic anticancer treatment were randomized 1:1 to digital symptom monitoring plus usual care or usual care alone and followed up for 18 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Digital symptom monitoring combined weekly symptom reporting using the Integrated Palliative Care Outcome Scale, automated self-management guidance, and nurse-led follow-up for severe symptom alerts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was change in HRQOL as measured by EuroQol 5-dimension 5-level (EQ-5D-5L) assessment. Secondary outcomes included self-efficacy (6-item Self-Efficacy for Managing Chronic Disease Scale), Eastern Cooperative Oncology Group performance status (ECOG PS), ED visits, and hospitalizations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 1214 randomized participants (590 to digital symptom monitoring and 624 to usual care; median age, 78 [range, 31-103] years; 617 [50.8%] male), including 821 caregivers (67.6%) as application users, HRQOL was better maintained with digital symptom monitoring at week 18. Mean changes from baseline favored the intervention compared with usual care for EQ-5D-5L utility (0.49 to 0.52 vs 0.50 to 0.38; mean difference in change, \u22120.15 [95% CI, \u22120.21 to \u22120.10];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) and EQ-5D visual analogue scale (63.16 to 65.72 vs 63.87 to 59.69; mean difference, \u22126.09 [95% CI, \u22128.67 to \u22123.51] points;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Self-efficacy was better maintained with the digital symptom monitoring intervention (5.29 to 5.34 vs 5.43 to 4.87; mean difference, \u22120.53 [95% CI, \u22120.78 to \u22120.27];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Deterioration in ECOG PS (44 of 367 [12.0%] vs 66 of 379 [17.4%]; odds ratio [OR], 1.22 [95% CI, 0.83-1.79];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.31) and ED utilization (74 of 367 [20.2%] vs 97 of 379 [25.6%]; OR, 1.27 [95% CI, 0.97-1.67];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.09) were similar between groups. Hospitalization outcomes favored  digital symptom monitoring, including fewer participants with worsening unplanned hospitalization episodes (63 of 367 [17.2%] vs 108 of 379 [28.5%]; OR, 1.59 [95% CI, 1.21-2.10];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.001) and fewer inpatient days during follow-up (mean [SD], 3.4 [8.9] vs 7.3 [15.5]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this randomized clinical trial of patients with advanced cancer, an app-facilitated palliative care intervention helped maintain HRQOL and self-efficacy and reduced acute care use compared with usual care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT07475312\">NCT07475312<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.15509","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:30:11Z","timestamp":1780335011000},"page":"e2615509","source":"Crossref","is-referenced-by-count":1,"title":["Digital Self-Management of Symptoms and Quality of Life for Patients With Advanced Cancer"],"prefix":"10.1001","volume":"9","author":[{"given":"Wing-Lok","family":"Chan","sequence":"first","affiliation":[{"name":"Department of Clinical Oncology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region (SAR)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inda Sung","family":"Soong","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ying","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Princess Margaret Hospital, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie Wing-Yan","family":"Tin","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Wai-Kwan","family":"Siu","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Queen Mary Hospital, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Medicine and Geriatrics, Haven of Hope Hospital, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ling","family":"Tai","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region (SAR)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Mei","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region (SAR)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yu","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region (SAR)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Lo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Ho-Fun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region (SAR)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-Keung","family":"Yuen","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Queen Mary Hospital, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Kwong","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region (SAR)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Hui","sequence":"additional","affiliation":[{"name":"Centre of Cancer Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"1","key":"zoi260442r1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jpainsymman.2006.10.015","article-title":"Symptom prevalence in patients with incurable cancer: a systematic review.","volume":"34","author":"Teunissen","year":"2007","journal-title":"J Pain Symptom Manage"},{"issue":"9","key":"zoi260442r2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1200\/JCO.19.00470","article-title":"Palliative care and the management of common distressing symptoms in advanced cancer: pain, breathlessness, nausea and vomiting, and fatigue.","volume":"38","author":"Henson","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi260442r3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.50423","article-title":"Trends and characteristics of potentially preventable emergency department visits among patients with cancer in the US.","volume":"6","author":"Alishahi Tabriz","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi260442r4","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/hex.13254","article-title":"Patient-reported outcome measures (PROMs): a review of generic and condition-specific measures and a discussion of trends and issues.","volume":"24","author":"Churruca","year":"2021","journal-title":"Health Expect"},{"issue":"5","key":"zoi260442r5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.5811\/westjem.2021.5.51118","article-title":"Cancer-related emergency department visits: comparing characteristics and outcomes.","volume":"22","author":"Nene","year":"2021","journal-title":"West J Emerg Med"},{"issue":"6","key":"zoi260442r6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial.","volume":"34","author":"Basch","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1647","key":"zoi260442r7","doi-asserted-by":"publisher","first-page":"n1647","DOI":"10.1136\/bmj.n1647","article-title":"Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART).","volume":"374","author":"Maguire","year":"2021","journal-title":"BMJ"},{"issue":"11","key":"zoi260442r8","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1007\/s00520-018-4232-z","article-title":"Feasibility and accessibility of electronic patient-reported outcome measures using a smartphone during routine chemotherapy: a pilot study.","volume":"26","author":"Bae","year":"2018","journal-title":"Support Care Cancer"},{"key":"zoi260442r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2022.104931","article-title":"Patient-facing cancer mobile apps that enable patient reported outcome data to be collected: a systematic review of content, functionality, quality, and ability to integrate with electronic health records.","volume":"170","author":"Vercell","year":"2023","journal-title":"Int J Med Inform"},{"issue":"10","key":"zoi260442r10","doi-asserted-by":"publisher","DOI":"10.2196\/11231","article-title":"Benefits of mobile apps in pain management: systematic review.","volume":"6","author":"Thurnheer","year":"2018","journal-title":"JMIR Mhealth Uhealth"},{"key":"zoi260442r11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1200\/CCI.20.00015","article-title":"Electronic patient-reported outcome-based interventions for palliative cancer care: a systematic and mapping review.","volume":"4","author":"Karamanidou","year":"2020","journal-title":"JCO Clin Cancer Inform"},{"issue":"8","key":"zoi260442r12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1177\/0269216319854264","article-title":"A brief, patient- and proxy-reported outcome measure in advanced illness: validity, reliability and responsiveness of the Integrated Palliative Care Outcome Scale (IPOS).","volume":"33","author":"Murtagh","year":"2019","journal-title":"Palliat Med"},{"issue":"10","key":"zoi260442r13","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"zoi260442r14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1477-7525-5-70","article-title":"Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer.","volume":"5","author":"Pickard","year":"2007","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"zoi260442r15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40271-017-0278-0","article-title":"Assessing the use of a feedback module to model EQ-5D-5L health states values in Hong Kong.","volume":"11","author":"Wong","year":"2018","journal-title":"Patient"},{"issue":"2","key":"zoi260442r16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40271-020-00466-z","article-title":"Measurement properties of the EQ-5D-5L and EQ-5D-3L in six commonly diagnosed cancers.","volume":"14","author":"Zeng","year":"2021","journal-title":"Patient"},{"issue":"3","key":"zoi260442r17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11136-020-02688-y","article-title":"Psychometric properties of the EQ-5D-5L: a systematic review of the literature.","volume":"30","author":"Feng","year":"2021","journal-title":"Qual Life Res"},{"issue":"6","key":"zoi260442r19","first-page":"256","article-title":"Effect of a self-management program on patients with chronic disease.","volume":"4","author":"Lorig","year":"2001","journal-title":"Eff Clin Pract"},{"issue":"7-8","key":"zoi260442r20","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/jocn.12298","article-title":"The reliability and validity of the Chinese version of the Short-form Chronic Disease Self-Efficacy Scales for older adults.","volume":"23","author":"Chow","year":"2014","journal-title":"J Clin Nurs"},{"key":"zoi260442r21","doi-asserted-by":"publisher","DOI":"10.2196\/53834","article-title":"Patients\u2019 and clinicians\u2019 experiences using a real-time remote monitoring system for chemotherapy symptom management (ASyMS): qualitative study.","volume":"26","author":"McCann","year":"2024","journal-title":"J Med Internet Res"},{"issue":"9","key":"zoi260442r22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.33153","article-title":"Essential components of an electronic patient-reported symptom monitoring and management system: a randomized clinical trial.","volume":"7","author":"Mooney","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi260442r23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.9852","article-title":"Remote symptom monitoring with electronic patient-reported outcomes in clinical cancer populations.","volume":"8","author":"Rocque","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"8","key":"zoi260442r24","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1177\/02692163241257578","article-title":"Electronic symptom monitoring for home-based palliative care: a systematic review.","volume":"38","author":"Mao","year":"2024","journal-title":"Palliat Med"},{"issue":"2","key":"zoi260442r25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00520-017-3877-3","article-title":"Development and feasibility of a web application to monitor patients\u2019 cancer-related pain.","volume":"26","author":"Oldenmenger","year":"2018","journal-title":"Support Care Cancer"},{"issue":"9","key":"zoi260442r26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s40273-013-0081-2","article-title":"The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue.","volume":"31","author":"Carlotto","year":"2013","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"zoi260442r27","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.jtho.2019.02.005","article-title":"Cost-Effectiveness of web-based patient-reported outcome surveillance in patients with lung cancer.","volume":"14","author":"Liz\u00e9e","year":"2019","journal-title":"J Thorac Oncol"},{"key":"zoi260442r28","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.787135","article-title":"The cost-effectiveness of digital health interventions: a systematic review of the literature.","volume":"10","author":"Gentili","year":"2022","journal-title":"Front Public Health"},{"key":"zoi260442r29","doi-asserted-by":"publisher","DOI":"10.2196\/45145","article-title":"The impact of digital technology on self-management in cancer: systematic review.","volume":"9","author":"Lim","year":"2023","journal-title":"JMIR Cancer"},{"key":"zoi260442r30","doi-asserted-by":"publisher","DOI":"10.2196\/59632","article-title":"AI applications for chronic condition self-management: scoping review.","volume":"27","author":"Hwang","year":"2025","journal-title":"J Med Internet Res"},{"key":"zoi260442r18","unstructured":"Guide to the methods of technology appraisal 2013. National Institute for Health and Care Excellence. April 4, 2013. Accessed March 30, 2026. https:\/\/www.nice.org.uk\/process\/pmg9\/resources\/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781?"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2849792\/chan_2026_oi_260442_1779819160.17608.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:30:14Z","timestamp":1780335014000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2849792"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.15509","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}